US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 4.950
  • +0.330+7.14%
Close Nov 27 16:00 ET
  • 4.920
  • -0.030-0.61%
Post 18:35 ET
160.75MMarket Cap-2861P/E (TTM)

Candel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Candel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q431.000K / 14.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q431.000K / 14.000K--

Unlock Free Earnings Estimates

Candel Therapeutics Earnings Reports

  • Candel Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 08:37 ET

  • Candel Therapeutics | 8-K: Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

    Nov 14 08:21 ET

  • Candel Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 08:32 ET

  • Candel Therapeutics | 8-K: Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

    Aug 13 08:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data